Researchers map how immune cells fight HIV, opening doors to better vaccines

A new editorial synthesizes evidence on CD8+ T-cells—immune soldiers that control HIV infection—and their role in experimental vaccines and treatments. For biotech companies and health agencies, this roadmap clarifies which immune strategies show the most promise for developing an effective HIV vaccine, a goal that has eluded researchers for decades.

Originaltitel: Editorial: CD8+T-cells in HIV/SIV infection, prophylaxis, and therapy